Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
about
Calculated Antibiosis of Acute Cholangitis and CholecystitisAcute Bacterial Cholangitis2013 WSES guidelines for management of intra-abdominal infections.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment.Risk factors of organ failure in cholangitis with bacteriobiliaMetagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteriaConservative management of cholestasis with and without fever in acute biliary pancreatitis.Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients.Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute CholangitisMicrobiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies.In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitisEmergency endoscopic retrograde cholangiopancreatography in critically ill patients is a safe and effective procedure.Ascending cholangitis presenting with Lactococcus lactis cremoris bacteraemia: a case report.How Does Aging Affect Presentation and Management of Biliary Stones?Cholangiohepatitis in Dairy Cattle: 13 Cases.Acute Cholangitis After Bilioenteric Anastomosis for Bile Duct Injuries.Endoscopic management of acute cholangitis as a result of common bile duct stones.[Treatment of postoperative impairment of gastrointestinal motility, cholangitis and pancreatitis].TG13 antimicrobial therapy for acute cholangitis and cholecystitis.Selection of prophylactic antibiotics according to the microorganisms isolated from surgical site infections (SSIs) in a previous series of surgeries reduces SSI incidence after pancreaticoduodenectomy.Evaluation of compliance with the Tokyo Guidelines for the management of acute cholangitis based on the Japanese administrative database associated with the Diagnosis Procedure Combination system.Clarifying the role of adjunctive metronidazole in the treatment of biliary infections.Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.Temporary placement of a covered duodenal stent can avoid riskier anterograde biliary drainage when ERCP for obstructive jaundice fails due to duodenal invasion.Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial.Acute cholangitis - an update.Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience.Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis.Successful treatment of Providencia rettgeri cholecystitis and neutrophilic cholangitis in a cat.Abnormal presentation of ascending cholangitis.
P2860
Q26780350-D880B100-886B-4BE0-BE00-23CF2846595BQ26782881-AB298CDA-4A54-4BEB-A875-0BB9B4A47D35Q34321150-F0401DA9-768A-4EBE-9CD8-E295D9208D52Q34541183-5450F89E-660E-4D5D-A132-7ACCA3C26ED1Q35598398-27D445CD-CC7E-4CE4-ACA2-A9016421A666Q35783932-3A417197-B855-4ED8-A4E3-915EF3A5F5ADQ35857415-C3270966-F375-4432-AD09-D8974936A0FDQ35904122-575CA048-A321-48FD-9CF4-25ABC59AB12FQ36105556-F38F47C0-8CA9-4F9E-8DF6-2A40D81937FDQ36107458-896BF984-6CDE-4DB5-98FC-E7785D15156EQ36246303-B84072FF-055A-4CF4-86F6-0D469B6FAB1FQ37206914-42E7E57F-BF4E-46D8-A23F-2CEB96DC46E2Q37267273-0AFE0139-0A25-4FB5-A0F1-3D4EAFA9DD27Q38609137-42C4F30A-0923-4348-86A6-F8CE48674107Q38963376-FA1E39F1-4B82-477D-BEF3-2E74592AD564Q38965952-39880C72-955E-4EA8-8D2A-F63F9C147699Q40064838-199BB9A8-1F56-4DAC-974A-1D0474783B61Q40108238-41CB40E7-3709-41D4-9FBC-B46DD4164AADQ40244386-66479578-33EF-4B9A-9549-57BFCBA187F6Q41221240-37FCDA10-D87F-44AD-82AC-491FA555CE22Q42277917-FA2EF222-5126-4CFC-A022-6256DE2222CCQ43477764-19070BD5-7F7E-46F4-8305-B24A04AAAC6AQ43577580-70ADE331-E0B1-4F0D-AA69-098A393BB76EQ43862173-1E57B4FF-9E9D-463E-8801-B2A60767B772Q46770277-B7073243-E266-4D3E-9EE5-9C96B6C79475Q48193030-CCC7D65C-5641-4059-828B-66ECF9FF8E77Q50279855-61733903-EA00-449C-B6C8-F19F238FE10DQ50349774-D1E4ADF8-2FCA-45FF-B017-F3CE9DB36004Q50894046-0C7A7AD6-E77C-4B69-AE3B-FBD1E7E4AC95Q51038834-E0C23345-7F9D-46F9-B9BF-A2C582475BA5Q52699889-6E52588C-29D8-4EB4-B490-BCACD7BF2CECQ55113482-C67772A5-90F3-43F2-8254-B020BD5B6E54
P2860
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
@en
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.
@nl
type
label
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
@en
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.
@nl
prefLabel
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
@en
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.
@nl
P2093
P2860
P1476
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
@en
P2093
Atsushi Tanaka
Chen-Guo Ker
Eduardo de Santibanes
Fumihiko Miura
Giulio Belli
Harumi Gomi
Henry A Pitt
Jacques Belghiti
Keita Wada
Kui-Hin Liau
P2860
P356
10.1007/S00534-006-1157-6
P577
2007-01-30T00:00:00Z